LSCRX | VSCIX | LSCRX / VSCIX | |
Total Expense Ratio | 1.15 | 0.04 | 2,875% |
Annual Report Gross Expense Ratio | 1.21 | 0.04 | 3,025% |
Fund Existence | 29 years | 28 years | - |
Gain YTD | 4.658 | 6.250 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 339M | 161B | 0% |
Annual Yield % from dividends | 0.03 | 1.32 | 2% |
Returns for 1 year | -4.84 | 8.04 | -60% |
Returns for 3 years | 3.01 | 50.85 | 6% |
Returns for 5 years | 5.08 | 71.75 | 7% |
Returns for 10 years | -28.11 | 149.00 | -19% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FLEU | 31.88 | 0.52 | +1.65% |
Franklin FTSE Eurozone ETF | |||
CCNR | 30.54 | 0.35 | +1.14% |
ALPS/CoreCommodity Natural Resources ETF | |||
ARKG | 26.91 | 0.24 | +0.90% |
ARK Genomic Revolution ETF | |||
MSLC | 54.07 | 0.29 | +0.54% |
Morgan Stanley Pathway Large Cap Eq ETF | |||
XSLV | 46.35 | 0.20 | +0.43% |
Invesco S&P SmallCap Low Volatility ETF |